Skip to main content

Table 2 Clinical characteristics and laboratory findings of enrolled TB mortality cases categorized by genders

From: Clinical profiles of early and tuberculosis-related mortality in South Korea between 2015 and 2017: a cross-sectional study

Variablesa All
(n = 3735)
Male
(n = 2541)
Female
(n = 1194)
p-value
Prior TB history
 No 3033 (81.2%) 1978 (77.8%) 1055 (88.4%) 0.000
 Yes 677 (18.1%) 547 (21.5%) 130 (10.9%)  
Comorbidities
 Diabetes Mellitus 947 (25.4%) 647 (25.5%) 300 (25.1%) 0.863
 Chronic lung disease 259 (6.9%) 203 (8.0%) 56 (4.7%) 0.000
 Cardiovascular disease 362 (9.7%) 206 (8.1%) 156 (13.1%) 0.000
 Malignancy 782 (20.9%) 630 (24.8%) 152 (12.7%) 0.000
 HIV infection 12 (0.3%) 12 (0.5%) 0 (0.0%) 0.017
 No reported illness 778 (20.8%) 532 (20.9%) 246 (20.6%) 0.848
Symptoms
 Cough 1641 (43.9%) 1129 (44.4%) 512 (42.9%) 0.369
 Dyspnea 1250 (33.5%) 861 (33.9%) 389 (32.6%) 0.427
 Haemoptysis 132 (3.5%) 94 (3.7%) 38 (3.2%) 0.424
 Fever 509 (13.6%) 342 (13.5%) 167 (14.0%) 0.664
Cavitation on CXR
 Normal 110 (2.9%) 69 (2.7%) 41 (3.4%) 0.000
 Non-cavitary disease 2714 (72.7%) 1781 (70.1%) 933 (78.1%)  
 Cavitary disease 873 (23.4%) 666 (26.2%) 207 (17.3%)  
Lesion extension on CXR
 Normal 110 (2.9%) 69 (7.1%) 41 (3.4%) 0.624
 Unilateral disease 1998 (53.5%) 1355 (53.3%) 643 (53.9%)  
 Bilateral disease 1508 (40.4%) 1035 (40.7%) 473 (39.6%)  
AFB smear test
 Negative 1889 (50.6%) 1279 (50.3%) 610 (51.1%) 0.000
 Positive 1753 (46.9%) 1221 (48.1%) 532 (44.6%)  
AFB culture test
 Negative 989 (26.5%) 693 (27.3%) 296 (24.8%) 0.021
 Positive 2529 (67.7%) 1717 (67.6%) 812 (68.0%)  
Initial treatment regimen
 HERZ 3042 (81.4%) 2093 (82.4%) 949 (79.5%) 0.097
 HRE 310 (8.3%) 203 (8.0%) 107 (9.0%)  
 No treatment 383 (10.3%) 245 (9.6%) 138 (11.6%)  
  1. TB tuberculosis, CXR chest X-ray, AFB acid-fast bacilli, HREZ combination regimen of isoniazid, rifampicin, ethambutol, and pyrazinamide, HRE combination regimen of isoniazid, rifampicin, and ethambutol
  2. a Missing data and values were not shown in this table